Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation

References

• Du C, Bhatia M, Tang SCW, Zhang M, Steiner T. Mediators of inflammation: inflammation in cancer, chronic diseases, and wound healing. Mediators Inflamm. 2015, 570653 (2015).
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier J-P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann. Rheum. Dis. 62(6), 501–509 (2003).
   PubMed Web of Science ®Google Scholar
• Wang T, Fu X, Chen Q et al. Arachidonic acid metabolism and kidney inflammation. Int. J. Mol. Sci. 20(15), 3683 (2019).
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 345(6), 433–442 (2001).
   PubMed Web of Science ®Google Scholar
• Jouzeau JY, Terlain B, Abid A, Nédélec E, Netter P. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs 53(4), 563–582 (1997).
   PubMed Web of Science ®Google Scholar
• Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265(28), 16737–16740 (1990).
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Oates JC, McCune WJ et al. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: a report of four cases. Arthritis Rheum. 43(8), 1891–1896 (2000).
   PubMed Web of Science ®Google Scholar
• Epstein FH, Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N. Engl. J. Med. 323(10), 645–655 (1990).
   PubMed Web of Science ®Google Scholar
• Gallin JI, Snyderman R. Inflammation: Basic principles and clinical correlates (3rd Edition). Fearon DT, Haynes BF, Nathan C ( Eds). Lippincott Williams & Wilkins, PA, USA (1999).
   Google Scholar
• Labat C, Temmar M, Nagy E et al. Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis. J. Hypertens. 31(11), 2251–2258 (2013).
   PubMed Web of Science ®Google Scholar
• Bell RL, Young PR, Albert D et al. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor. Int. J. Immunopharmacol. 14(3), 505–510 (1992).
   PubMed Web of Science ®Google Scholar
• Joshi EM, Heasley BH, Chordia MD, Macdonald TL. In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity. Chem. Res. Toxicol. 17(2), 137–143 (2004).
   PubMed Web of Science ®Google Scholar
• Wallace JL. Eicosanoids in the gastrointestinal tract. Br. J. Pharmacol. 176(8), 1000–1008 (2019).
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Vu T-Y, Chandi V, Polimati H, Tatipamula VB. Dual COX and 5-LOX inhibition by clerodane diterpenes from seeds of Polyalthia longifolia (Sonn.) Thwaites. Sci. Rep. 10(1), 15965 (2020).
   PubMed Web of Science ®Google Scholar
• Kaur G, Silakari O. Multiple target-centric strategy to tame inflammation. Future med. Chem. 9(12), 1361–1376 (2017).
   PubMed Web of Science ®Google Scholar
• Meshram MA, Bhise UO, Makhal PN, Kaki VR. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: structural aspects and SAR. Eur. J. Med. Chem. 225, 113804 (2021).
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang B, Li J et al. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX. Eur. J. Med. Chem. 180, 41–50 (2019).
   PubMed Web of Science ®Google Scholar
• Kumar S, Ritika. A brief review of the biological potential of indole derivatives. Future J. Pharm. Sci. 6(1), 121 (2020).
   Web of Science ®Google Scholar
• Wylie G, Appelboom T, Bolten W et al. A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. Br. J. Rheumatol. 34(6), 554–563 (1995).
   PubMedGoogle Scholar
• Lai Y, Ma L, Huang W et al. Synthesis and biological evaluation of 3-4-(amino/methylsulfonyl)phenylmethylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors. Bioorg. Med. Chem. Lett. 20(24), 7349–7353 (2010).
   PubMed Web of Science ®Google Scholar
• Rafferty M, Johnson G. Benzoic acid and benzoic acid ester derivatives having anti-inflammatoryand analgesic activity. 811,567 (December 20, 1985). US4689182A
   Google Scholar
• Kalgutkar AS, Crews BC, Saleh S, Prudhomme D, Marnett LJ. Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors. Bioorg. Med. Chem. 13(24), 6810–6822 (2005).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Elsaady MT, Amin NH, Hefny AA. Design, synthesis and biological evaluation of some novel indole derivatives as selective COX-2 inhibitors. J. App. Pharm. Sci. 7(08), 69–77 (2017).
   Google Scholar
• Hlasta DJ, Casey FB, Ferguson EW et al. 5-Lipoxygenase inhibitors: the synthesis and structure–activity relationships of a series of 1-phenyl-3-pyrazolidinones. J. Med. Chem. 34(5), 1560–1570 (1991).
   PubMed Web of Science ®Google Scholar
• Kurumbail RG, Stevens AM, Gierse JK et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384(6610), 644–648 (1996).
   PubMed Web of Science ®Google Scholar
• Jha M, Shelke GM, Kumar A. Catalyst-free one-pot tandem reduction of oxo and ene/yne functionalities by hydrazine: synthesis of substituted oxindoles from isatins. Eur. J. Org. Chem. 2014(16), 3334–3336 (2014).
   Web of Science ®Google Scholar
• Wenkert E, Bhattacharyya NK, Reid TL, Stevens TE. Alkylation of oxindoles. J. Am. Chem. Soc. 78(4), 797–801 (1956).
   Web of Science ®Google Scholar
• Horner L. Synthesen in der Oxindolreihe. Justus Liebigs Ann. Chem. 548(1), 117–146 (1941).
   Google Scholar
• Zhang L-L, Da B-C, Xiang S-H et al. Organocatalytic double arylation of 3-isothiocyanato oxindoles: stereocontrolled synthesis of complex spirooxindoles. Tetrahedron 75(12), 1689–1696 (2019).
   Web of Science ®Google Scholar
• Shaw J, Gosain R, Kalita MM et al. Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy. eLife 9, e52555 (2020). doi: 10.7554/elife.52555
   PubMed Web of Science ®Google Scholar
• George RF, Said MF, Bua S, Supuran CT. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII. Bioorg. Chem. 95, 103514 (2020).
   PubMed Web of Science ®Google Scholar
• Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544–547 (1962).
   PubMed Web of Science ®Google Scholar
• Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol Chemotherapy 32(2), 295–310 (1968).
   PubMed Web of Science ®Google Scholar
• Heinisch O. Finney DJ. statistical method in biological assay. 2. Aufl. Charles Griffin & Cc. Ltd., London 1964. XIX + 668 S., Preis 105 s. Biom. J. 7(3), 206 (1965).
   Google Scholar
• Meshali M. El-Sabbagh H. Foda A. Effect of encapsulation of flufenamic acid with acrylic resins on its bioavailability and gastric ulcerogenic activity in rats. Acta. Pharm. Technol. 29, 217–219 (1983).
   Google Scholar
• Robert A, Nezamis JE, Phillips JP. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the Rat. Gastroenterology 55(4), 481–487 (1968).
   PubMed Web of Science ®Google Scholar
• Bancroft J.D. Stevans A. Tumer D.R. Theory and Practice of Histological Techniques (4th edition). Churchill Livingstone, Edinburgh, London, Melbourne, New York (2013).
   Google Scholar
• Kim T.H., Jeon E.J., Cheung D.Y. etal. Gastroprotective effects of grape seed proanthocyanidin extracts against nonsteroid anti-inflammatory drug-induced gastric injury in rats. Gut Liver. 7, 282–289 (2013).
   PubMed Web of Science ®Google Scholar
• Xu S, Hermanson DJ, Banerjee S et al. Crystal structure of ovine cyclooxygenase-1 complex with meloxicam. (2014). doi: https://www.rcsb.org/structure/4olz
   Google Scholar
• Kiefer JR, Kurumbail RG, Stallings WC, Pawlitz JL. Structure of celecoxib bound at the COX-2 active site. (2010). doi: http://www.rcsb.org/structure/3Inl
   Google Scholar
• Gilbert NC, Bartlett SG, Waight MT et al. The structure of human 5-lipoxygenase. Science 331(6014), 217–219 (2011).
   PubMed Web of Science ®Google Scholar
• Bell EW, Zhang Y. DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J. Cheminform. 11(1), 40 (2019).
   PubMed Web of Science ®Google Scholar
• Hood WF, Gierse JK, Isakson PC et al. Characterization of celecoxib and valdecoxib binding to cyclooxygenase. Mol. Pharmacol. 63(4), 870–877 (2003).
   PubMed Web of Science ®Google Scholar
• Kiefer JR, Pawlitz JL, Moreland KT et al. Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature 405(6782), 97–101 (2000).
   PubMed Web of Science ®Google Scholar
• Redzicka A, Szczukowski Ł, Kochel A, Wiatrak B, Gębczak K, Czyżnikowska Ż. COX-1/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases. Bioorg. Med. Chem. 27(17), 3918–3928 (2019).
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1(4), 337–341 (2004).
   PubMedGoogle Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 46(1–3), 3–26 (2001).
   PubMed Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45(12), 2615–2623 (2002).
   PubMed Web of Science ®Google Scholar
• Delaney JS. ESOL: estimating aqueous solubility directly from molecular structure. J. Chem. Inf. Comput. Sci. 44(3), 1000–1005 (2004).
   PubMedGoogle Scholar
• Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin. Pharmacokinet. 42(1), 59–98 (2003).
   PubMed Web of Science ®Google Scholar
• Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 43(21), 3867–3877 (2000).
   PubMed Web of Science ®Google Scholar
• Martin YC. A bioavailability score. J. Med. Chem. 48(9), 3164–3170 (2005).
   PubMed Web of Science ®Google Scholar
• Guideline on BioanalyticalMethod Validation. EMA. www.ema.europa.eu/en/documents/scientific-guidline/guidline-bioanalytical-method-validation_en.pdf.
   Google Scholar